The letter of cooperation for Walden IRB: who signs, what it must name, and why it holds files up

What is a letter of cooperation — and who counts as a community partner?

Walden's application materials use the phrase "community partner" broadly, and deliberately: schools, clinics, businesses, non-profits, government entities, residential facilities — any organization involved in your research project. If an organization will help identify potential participants, host data collection, distribute your invitation, or hand over records that are not public, it is a partner, and its involvement has to be documented rather than assumed. The letter of cooperation is that documentation: not a note of enthusiasm, not a supportive email from a colleague who likes the project, but the organization itself, in writing, permitting named research activities on its ground.

The distinction the board is drawing is between goodwill and authority. A unit manager's encouragement is goodwill. The letter converts it into something the board can act on: evidence that the organization knows what the study involves and has agreed, through someone empowered to agree, to let it happen.

Who signs it, and what makes the signature valid?

Walden's application asks you to name the individual authorized to approve research within each partner organization — and the template's own confirmation line makes the signer attest to being "authorized to approve research in this setting," with the plan complying with the organization's policies. That sentence is the letter's load-bearing wall. The person who signs is not necessarily the person who likes you or the person you report to; it is the person whose role lets them commit the organization — an administrator, a director, an executive, whatever the setting's own structure says. Signing over that sentence without the authority behind it is the failure the wording exists to prevent, so the practical first step at any site is a quiet question: who here can approve research?

Two mechanics worth knowing. Walden's template language has long provided for electronic signature under the university's e-signature policy, so a scanned or electronically signed letter is not, by itself, a defect — the current portal's instructions govern the details. And the letter reads best as the organization speaking: on its own identity and stationery, from the signer's official address, so the authority the sentence claims is visible on the face of the page.

What must the letter actually say?

Walden publishes a sample letter of cooperation through its IRB materials, and the letters the board accepts follow its logic. Drafted for your study, the letter says, in order:

• That the signer has reviewed the proposal and grants permission for you to conduct the study — named by its actual title, so there is no doubt which plan was approved.
• Which activities are authorized, specifically: recruiting from the organization's staff or clients, distributing a survey, conducting interviews on site, accessing a defined set of records. This clause does the real work, and it must match the application — a letter permitting a questionnaire does not cover the interviews the application describes.
• That individuals' participation is voluntary and at their own discretion — the organization permits the ask; it does not deliver its people.
• That the organization may withdraw if its circumstances change — a clause partners appreciate, because it makes the permission revocable rather than a blank cheque.
• What happens to the data — Walden's sample language keeps collected data confidential and restricts it from leaving the researcher's supervising faculty without the Walden IRB's permission, which is a promise your data security plan must be able to keep word for word.
• The signer's name, role, and signature, under the authority sentence above.

Because the wording of Walden's current sample is maintained in the IRB's own materials, build from the version the portal provides for your term rather than a letter borrowed from a finished study; the current handbook and portal govern. What does not change is the matching rule: every activity the application claims at that site appears in the letter, and nothing in the letter contradicts the consent document or the recruitment materials that will run under it.

When is the letter needed — and when is it filed?

Later than most candidates fear, and earlier than most partners move. In Walden's current process the ethics review starts with Form A, the description of data sources and partner sites; from those answers, the IRB office itself tells you which documents your particular study requires, letters of cooperation included. Walden's own guidance is explicit that not every partner-organization study needs a letter — the IRB will say whether written permission is required — and that you may begin the forms before your partner site is even settled. So the letter is not a prerequisite for starting; it is a dependency for finishing.

Its timing is also unusual in one respect: Walden's application materials have treated letters of cooperation and data use agreements as the documents that are signed before IRB approval — signed by the partner, then submitted alongside the application, with the file incomplete until they arrive. Read those two facts together and the strategy writes itself: open the conversation with the site early, let Form A and the IRB's document list confirm exactly what is needed, and have the letter drafted and ready for signature the moment the application is assembled. A letter chased after filing is the definition of avoidable waiting.

What if the partner wants Walden's approval first?

It happens, especially with health systems and agencies that have their own review machinery: the organization will not issue its formal permission until Walden has approved the study. Walden's application has carried a path for exactly this standoff — the researcher indicates that a funder or partner requires a copy of Walden's approval before granting formal approval, and seeks the board's approval conditioned on the partner's documentation following. Whether and how that option applies to your file is the board's call under the current portal; what matters is that a partner's "you first" is a known situation with a procedural answer, not a dead end. A site with its own IRB or research office may also run its own review — which board reads first is settled between the site and Walden's IRB, and the file should be built expecting both readers.

When does a data use agreement join the letter?

When the partner will share records rather than merely open its doors. If the study uses an organization's non-public records — charts, rosters, results, personnel or academic data — Walden's materials require the terms of that sharing to be documented in a data use agreement, executed before approval and compliant with the privacy law that covers the records, HIPAA or FERPA as applicable. The agreement answers the questions a letter of cooperation does not: who owns the data, in what form it crosses to you, with which identifiers removed, under whose obligations. The letter permits; the agreement transfers. Records-based files typically need both, and they are drafted together so the activities, the identifiers, and the security promises line up across all three documents.

Why does this one page hold files up — and what shortens the wait?

Because it is the only enclosure with a second organization inside it. The letter waits on a signer's calendar, a compliance officer's reading, sometimes a committee that meets when it meets. None of that accelerates because your file is otherwise finished. What shortens the wait, in our experience carrying these files, is removing every reason for the site to hesitate: name the right signer before asking; send a draft on the organization's identity so no one there has to compose anything; keep the activities clause aligned with the application so legal review finds nothing to query; and ask once, completely, rather than three times incrementally. This is the page of the process this desk drafts most often — it is Lauren's corner of how it works — and the reason is exactly that a willing site and a usable letter are two different things.

One quiet afterlife note: the signed letter belongs to the IRB file, not to the published study. Walden's editorial guidance has treated the partner's identity as maskable in the final document, with the letter itself kept out of the appendices; the current handbook governs the details. Ask your partner what they expect, and promise only what the file can honor.

What to do next

Name the site, name the signer with authority, and list the activities your application will claim there — then get a draft letter in front of that signer while the rest of the file is still being assembled; the enclosure order is in the application checklist. If the site is willing but unsure what its letter must say, that is the exact gap this desk fills: write to us with where things stand, and we will read the file as the board will — the review is free.

Sources

• Walden University Quick Answers — common causes of delayed ethics approval (Form A first; the IRB confirms whether written partner permission is needed): academicanswers.waldenu.edu/faq/343947
• Walden-approved letter of cooperation, as published in Walden's repository (authority confirmation; permission, activities, voluntariness, withdrawal, confidentiality clauses): scholarworks.waldenu.edu — Walden dissertation, letter of cooperation appendix
• Walden University — Research Ethics Review Process (Office of Research and Doctoral Services; sign-in may be required): academicguides.waldenu.edu/research-center/research-ethics/review-process
• Walden University handbook — Doctoral Learning and Resources (IRB scope; approval before any data collection): academics.waldenu.edu/handbook/learning-modalities/doctoral-research-resources
• OHRP — Federal Policy for the Protection of Human Subjects (45 CFR 46): hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46